Scilex Holding Co (SCLXW)
Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTlido, a prescription lidocaine topical product approved by the FDA for the relief of neuropathic pain associated with PHN, which is a form of post-shingles nerve pain, and e GLOPERBA oral solutions, an FDA-approved prophylactic treatment for painful gout flares in adults. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.
Address
960 SAN ANTONIO ROAD
PALO ALTO, CA 94303
Founded
2020
Number of Employees
105
Website
http://www.scilexholding.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)